62 related articles for article (PubMed ID: 9494282)
1. Modulation of cholesterol metabolism affects tumor growth in hamsters.
Kishinaka M; Kuroki S; Shimura H; Chijiiwa K; Tanaka M
Fukuoka Igaku Zasshi; 1998 Jan; 89(1):11-9. PubMed ID: 9494282
[TBL] [Abstract][Full Text] [Related]
2. Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
Ugawa T; Kakuta H; Moritani H; Shikama H
Br J Pharmacol; 2002 Mar; 135(6):1572-8. PubMed ID: 11906972
[TBL] [Abstract][Full Text] [Related]
3. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
5. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
Pappu AS; Bacon SP; Illingworth DR
J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol synthesis in central nervous system of rat is affected by simvastatin as well as by atorvastatin.
Cibickova L; Hyspler R; Ticha A; Cibicek N; Palicka V; Cermakova E; Zadak Z
Pharmazie; 2008 Nov; 63(11):819-22. PubMed ID: 19069243
[TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on trioleylglycerol hydrolysis and transacylation with cholesterol in serum of outpatients with coronary heart disease.
Pioruńska-Stolzmann M; Pioruńska-Mikolajczak A; Mikolajczyk Z
Drugs Exp Clin Res; 2003; 29(1):37-43. PubMed ID: 12866362
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
[TBL] [Abstract][Full Text] [Related]
9. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase.
Singh DK; Li L; Porter TD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1020-6. PubMed ID: 16714400
[TBL] [Abstract][Full Text] [Related]
10. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
Rydgren T; Sandler S
Biochem Biophys Res Commun; 2009 Feb; 379(4):1076-9. PubMed ID: 19150339
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
13. The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.
Cibickova L; Hyspler R; Micuda S; Cibicek N; Zivna H; Jun D; Ticha A; Brcakova E; Palicka V
Steroids; 2009 Jan; 74(1):13-9. PubMed ID: 18817797
[TBL] [Abstract][Full Text] [Related]
14. The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol.
Flach J; Antoni I; Villemin P; Bentzen CL; Niesor EJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):240-6. PubMed ID: 10733934
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata.
Westermeyer C; Macreadie IG
FEMS Yeast Res; 2007 May; 7(3):436-41. PubMed ID: 17257373
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition.
Calişkan S; Calişkan M; Kuralay F; Onvural B
Res Exp Med (Berl); 2000 Feb; 199(4):189-94. PubMed ID: 10743676
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kawane T; Horiuchi N
Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Teupser D; Bruegel M; Stein O; Stein Y; Thiery J
Biochem Biophys Res Commun; 2001 Dec; 289(4):838-44. PubMed ID: 11735122
[TBL] [Abstract][Full Text] [Related]
20. Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption.
Bertolotti M; Zambianchi L; Carulli L; Simonini MS; Del Puppo M; Kienle MG; Loria P; Pinetti A; Carulli N
Hepatology; 2003 Oct; 38(4):939-46. PubMed ID: 14512881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
